Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Dietary Management

- PMLiVE

Innovate UK supports AI drug discovery project worth £1m

Project aims to use deep learning to utilise complex medicine data

- PMLiVE

Kymriah rejected in DLBCL – but NICE wants to keep talking about cost effectiveness

Kymriah faces harder test in DLBCL - especially with Yescarta competition

- PMLiVE

Biotech leaders jump into US free speech debate

Senior biotech execs sign a letter in defence of free speech

- PMLiVE

Q&A: Jenny Squibbs The best and worst things about working in healthcare comms

Gemma Jones interviews 90TEN's senior account director

- PMLiVE

Viking throws down gauntlet in NASH battle

Biotech is challenging rival Madrigal in 'next big thing' disease area

- PMLiVE

London cancer hub launched by Cancer Research UK

Specialist centres unite to collaborate on immunotherapies such as CAR-T

- PMLiVE

Rival Opdivo rejected, Novartis combo gets NICE green light in adjuvant melanoma

Proactive adjuvant treatment could extend melanoma patient lives

- PMLiVE

Tox trouble stalls Sosei/Allergan Alzheimer’s drug

Surprise findings from primate studies

Making a Difference – The Future of Pharma

On a global scale, pharma is one of the least-trusted industries. And this is despite the fact that pharma contributes more than £30 BN each year to the UK economy,...

Lucid Group Communications Limited

- PMLiVE

Teva wins FDA OK for crucial migraine drug

Vital to Teva's turnaround, Ajovy will challenge Novartis/Amgen's Aimovig

- PMLiVE

AZ prepares to file COPD triple, taking on rival GSK

Latest salvo in combination trials competition

- PMLiVE

Controversy grows around GP at Hand service after minister’s endorsement

Hancock says service should be rolled out across England

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links